BRITISH CANNABIS™ brand ACCESS CBD® was voted Best CBD Oil in Pharmacy for the second time, with CBD by BRITISH CANNABIS™ CBD Oils and Dermal Patches shortlisted for a further three categories.
The MVP Pharmacy Awards took place in November 2022 at a prestigious London venue –seeing the biggest manufacturers in the industry gather for a blend of dining and bowling in the hope of seeing their product crowned Most Valuable Product.
Winners were revealed during a celebratory gala lunch offering guests a fantastic evening where BRITISH CANNABIS™ ACCESS CBD® was voted Best CBD Oil in Pharmacy (for sleep issues, stress and insomnia) for the second time, and CBD by BRITISH CANNABIS™ CBD Oils and Dermal Patches were shortlisted for a further three categories.
The Award winners were published in an established supplement distributed by P3pharmacy and Pharmacy Magazine/Training Matters with a circulation of 30,000 copies.
Recognising the best in public-private partnerships
P3 Pharmacy Magazine readers voted from a selection of pharmacy’s Most Valuable Products that were available for the past 12 months in pharmacies. They pick the winners from the latest Food & Beverage, Beauty, Health & Personal Care, and Household products.
In addition, an expert panel offered high-level credibility alongside the usual pharmacy readership voting. Comprising 20 head office buyers and independent pharmacists, they included John Acland, Head of eCommerce & Category Management, Mhairi Smith, Lloyds Pharmacy and Senior Buying Manager at OTC Boots.
“There are so many new products launched each year, and consumers want to know which ones are the best and worth purchasing,” said BRITISH CANNABIS™ marketing director Steve Batchelor.
“It is increasingly difficult for brands to break through the clutter and succeed. This is where The MVP P3 Awards help the latest products stand out from the competition and brands gain an edge in the market.”
Champagne of CBD oils
With so many new products launched each year, it can be hard for customers to decide which ones are worth trying. However, the foundation of BRITISH CANNABIS™ is its already established brands, covering a diverse market sector with further brands in the pipeline.
For example: CBD by BRITISH CANNABIS™ was voted best CBD Oil UK by Your Healthy Living in 2020. This 100% Cannabis Oil is their best tasting and best-selling CBD oil supplement, its highly refined formula meets the exacting standards required by pharmacists and healthcare professionals.
ACCESS CBD™ is a range of high-quality, low-cost CBD oil food supplements from the same UK seed-to-shelf company, BRITISH CANNABIS™.
ACCESS CBD™ oils are made with a broad plant spectrum of natural cannabis phytochemicals, suspended in MCT oil. Naturally flavoured with real fruit flavours and dozens of naturally occurring cannabis terpenes and plant compounds, they are available in three great flavours – Berry, Citrus and Natural.
“We have also received multiple awards for our CBD RESCUE CREAM® and 75% THC-Free CBD Distillate; including ‘Best Pharmacy Product of The Year 2020’ by The Independent Community Pharmacist,” commented BRITISH CANNABIS™ CEO and founder, Tom Whettem.
“Our quality products are made from 100% cannabis to meet the exacting needs of the pharmacy market. Now listed in over 1000 pharmacies and growing.”
ACCESS CBD® is great value
Although ACCESS CBD® competes directly with many high-street CBD brands, at the time of launching in 2019, its products cost on average 70% less, CBD milligram for CBD milligram.
“Highly competitive pricing changed the landscape of what consumers pay for genuine CBD oils. ACCESS CBD® is still an affordable, genuine range of CBD supplements, regulated by UK Governing Authorities – and there’s data to back that up,” said Steve.
As an extra confidence builder to compliment this emerging health product category, British media doctor and health campaigner Dr Christian Jessen has an exclusive partnership with BRITISH CANNABIS™ where he answers CBD questions from consumers and patients in a deal running for at least two years.
In these video series, customers gather knowledge about CBD and cannabis-derived products, such as what’s legal, how can one start to select products and how to ensure confidence in them.
This article is sponsored by BRITISH CANNABIS™.
- Medical Cannabis Division of Rokshaw Ltd Rebranding to Curaleaf Laboratories
- Breaking Ground: Morama Holdings Pioneers High-Quality, Organic Cannabis in Lesotho
- Patients to call for equity in medical cannabis access at UN Commission on Narcotic Drugs
- Medical cannabis has ‘negligible’ impact on driving performance – study
- Research shows ‘remarkable’ effects of cannabis in treatment of skin cancer
- Optimism despite delays: Ireland’s journey toward cannabis decriminalisation
News4 months ago
FSA drops recommended daily dose of CBD to 10mg – everything you need to know
Pain5 months ago
Medical cannabis ‘effective’ and ‘fast-acting’ for neuropathic pain – study
News4 months ago
UK government accepts ACMD recommendations for CBD products
Industry4 months ago
First UK-grown cannabis medicine expected by end of 2023
News5 months ago
The Netherlands to launch cannabis legalisation pilot December 2023
News5 months ago
BBC documentary highlights ‘pot luck’ of access to cannabis on NHS
Science5 months ago
New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders
News4 months ago
Europe’s first legal cannabis dispensaries to open under sixth Swiss pilot